XML 25 R35.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Subsequent Events (Details) (Subsequent event, USD $) In Millions, unless otherwise specified |  | 0 Months Ended |
--- | --- | --- | ---
Oct. 01, 2012 Development and commercialization Alfa Wassermann Velusetrag (or TD-5108) | Oct. 03, 2012 Development and commercialization Alfa Wassermann Velusetrag (or TD-5108) Maximum | Oct. 19, 2012 Development and commercialization R-Pharm CJSC item | Oct. 19, 2012 Development and commercialization R-Pharm CJSC TD-1792 | Oct. 19, 2012 Development and commercialization R-Pharm CJSC Telavancin | Oct. 15, 2012 Discover, develop, and commercialize Merck Novel small molecule therapeutics
Information related to subsequent events |  |  |  |  |  |
Option fee funding amount | $ 10.0 |  |  |  |  |
Maximum potential development, regulatory and sales milestone payments eligible to receive | 53.5 |  |  |  |  |
Maximum royalties eligible to receive expressed as a percentage of net sales |  | 20.00% |  | 15.00% | 25.00% |
Upfront payment to be received |  |  |  |  |  | 5.0
Potential future payments to be received |  |  |  |  |  | 148.0
Number of separate development and commercialization agreements |  |  | 2 |  |  |
Maximum amount eligible to receive through near-term licensing fees |  |  | 2.0 |  |  |
Maximum amount eligible to receive by achieving future development milestones |  |  | 4.0 |  |  |
Maximum amount eligible to receive by achieving future sales milestones |  |  | $ 6.0 |  |  |

X
- Definition Represents the maximum royalties to be received by the entity from the other party in a collaborative arrangement, expressed as a percentage of net sales. + References No definition available. + Details
Name: | thrx_AnnualRoyaltiesPercentageOfNetSales
Namespace Prefix: | thrx_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the maximum amount eligible to receive under the collaborative arrangement through achieving development milestones. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementDevelopmentMilestonesReceive
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the maximum amount of potential future payments that may be received under the collaborative arrangement. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementMaximumPotentialFuturePayments
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the maximum amount eligible to receive under the collaborative arrangement for near-term licensing fees. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementNearTermLicensingFeesReceive
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the maximum amount eligible to receive under the collaborative arrangement through achieving net sales milestones. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementNetSalesMilestonesReceive
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the number of separate development and commercialization agreements with another entity. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementNumberOfSeparateDevelopmentAndCommercializationAgreements
Namespace Prefix: | thrx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the option fee funding amount that the entity is entitled to receive if exercised under the collaborative arrangement. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementOptionFeeFundingAmount
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the maximum amount of potential development, regulatory and sales milestone payments that the entity is entitled to receive under the collaborative arrangement. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementPotentialDevelopmentRegulatoryAndSalesMilestoneMaximumPaymentPotential
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the cumulative amount of upfront fees to be received under the collaborative arrangement. + References No definition available. + Details
Name: | thrx_CollaborativeArrangementUpfrontFeesToBeReceived
Namespace Prefix: | thrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration